US Stock MarketDetailed Quotes

TVTX Travere Therapeutic

Watchlist
  • 16.410
  • -0.700-4.09%
Close Oct 11 16:00 ET
  • 16.470
  • +0.060+0.37%
Post 17:37 ET
1.26BMarket Cap-9167P/E (TTM)

Travere Therapeutic Key Stats

Earnings

Revenue Breakdown

Financial Indicators

Income Statement

Balance Sheet

Cash Flow

Travere Therapeutic Earnings Estimates

Revenue

EPS

EBIT

Revenue is based on 13 analyst forecasts. Estimate data is from S&P, and actual data is from Income Statement

Currency: USD

Actual
Estimate
DatePeriodRevenue/EstimateEarnings Call
--2024/Q4-- / 71.378M--
--2024/Q3-- / 62.226M--
Aug 1, 20242024/Q254.116M / 52.686M--
May 6, 20242024/Q141.374M / 43.616M--
Feb 15, 20242023/Q445.059M / 41.816M--
DatePeriodRevenue/EstimateEarnings Call
--2024/Q4-- / 71.378M--
--2024/Q3-- / 62.226M--
Aug 1, 20242024/Q254.116M / 52.686M--
May 6, 20242024/Q141.374M / 43.616M--
Feb 15, 20242023/Q445.059M / 41.816M--

Unlock Free Earnings Estimates

Travere Therapeutic Earnings Reports

  • Travere Therapeutic | 10-Q: Q2 2024 Earnings Report

    Aug 1 16:42 ET

  • Travere Therapeutic | 10-Q: Q1 2024 Earnings Report

    May 6 16:51 ET

  • Travere Therapeutic | 10-K: FY2023 Annual Report

    Feb 20 08:13 ET

  • Travere Therapeutic | 10-Q: Q3 2023 Earnings Report

    Nov 7, 2023 17:14 ET

    • Read more

    Analysis

    Analyst Rating

    Updated: Oct 12, 2024

    Strong Buy

    • Buy

      78.57%

    • Hold

      21.43%

    • Sell

      0.00%

    Price Target

    No Data

    Heat List
    US
    Overall
    Symbol
    Latest Price
    % Chg

    No Data